We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

51 hedge funds and large institutions have $258M invested in Loxo Oncology, Inc in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

2% more funds holding

Funds holding: 50 → 51 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less capital invested

Capital invested by funds: $260M → $258M (-$2.47M)

18% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 17

Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
6
Increased
14
Reduced
17
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
+$6.98M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.51M
3
EAM
Eventide Asset Management
Massachusetts
+$1.87M
4
Invesco
Invesco
Georgia
+$1.58M
5
Axa
Axa
France
+$1.41M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$7.08M
2
JP Morgan Chase
JP Morgan Chase
New York
-$2.99M
3
BI
BVF Inc
California
-$1.64M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.43M
5
Millennium Management
Millennium Management
New York
-$847K
Name Holding Trade Value Shares
Change 		Change in
Stake
RFC
26
Russell Frank Company
Washington
$629K +$704K +35,995 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$593K -$188K -9,618 -22%
BCM
28
Bridgeway Capital Management
Texas
$524K – – –
BIM
29
BlackRock Investment Management
Delaware
$512K +$3.42K +175 +0.6%
TCIM
30
TIAA CREF Investment Management
New York
$451K – – –
ARTA
31
A.R.T. Advisors
New York
$447K +$501K +25,584 New
NFA
32
Nationwide Fund Advisors
Ohio
$261K – – –
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$248K – – –
DCM
34
DAFNA Capital Management
California
$205K -$9.78K -500 -4%
TA
35
Teachers Advisors
New York
$202K – – –
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$188K -$15K -766 -7%
BG
37
BlackRock Group
United Kingdom
$139K – – –
PAM
38
Panagora Asset Management
Massachusetts
$89K -$1.27K -65 -1%
AIG
39
American International Group
New York
$80K +$98 +5 +0.1%
Bank of America
40
Bank of America
North Carolina
$35K -$1.64K -84 -4%
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$29.1K +$19.9K +1,019 +157%
Wells Fargo
42
Wells Fargo
California
$18K -$7K -358 -26%
TRCT
43
Tower Research Capital (TRC)
New York
$17K +$18.6K +953 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$6K -$1.78K -91 -20%
Morgan Stanley
45
Morgan Stanley
New York
$6K +$1.31K +67 +23%
AIM
46
Advantage Investment Management
Iowa
$5K – – –
GT
47
Glenmede Trust
Pennsylvania
$5K – – –
UBS Group
48
UBS Group
Switzerland
$1K -$34.3K -1,753 -96%
Barclays
49
Barclays
United Kingdom
$1K -$2.15K -110 -73%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$84 +$94.4K +4,823 New
1
2
3

LOXO Hedge Fund Activity: Q3 2015 in Review

51 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2015, worth a combined $258M — down 0.95% from $260M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new LOXO positions and 4 closed out — a net gain of 2 holders — while 14 added to existing stakes and 17 trimmed.

The largest buyer was RS Investment Management, adding an estimated $6.98M. The largest seller was Deerfield Management, cutting an estimated $7.08M.

  • 51 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2015, up from 50 in Q2 2015.
  • Funds reported $258M of Loxo Oncology, Inc stock for Q3 2015, down 0.95% quarter-over-quarter.
  • 6 funds opened new Loxo Oncology, Inc positions in Q3 2015 and 4 closed out, a net change of +2 holders.
  • The largest Loxo Oncology, Inc buyer in Q3 2015 was RS Investment Management, an estimated $6.98M added.
  • The largest Loxo Oncology, Inc seller in Q3 2015 was Deerfield Management, an estimated $7.08M sold.

Based on aggregated 13F filings for Q3 2015.